RxDoctor Payments Data

Blair Troutman, PA

Physician Assistant · Huntersville, NCNPI 1124416110

Payments from drug & device makers

$663in general payments, 2019–2025

Across 22 payments — averaging $30.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$160
  • AstraZeneca$157
  • Boehringer Ingelheim$111
  • Pfizer$69
  • Bayer$43
  • Lilly USA, LLC$30
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$663100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$663 in reported general payments places this provider in the 60th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$37,019
Medicare patients
132
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$48,480
EliquisApixaban29$24,878
JardianceEmpagliflozin15$24,047
TrulicityDulaglutide18$20,832
SymbicortBudesonide/Formoterol Fumarate15$4,451
ZypitamagPitavastatin Magnesium12$2,719
Gabapentin94$2,231
Bupropion XlBupropion Hcl57$1,433
Albuterol Sulfate HfaAlbuterol Sulfate40$1,202
Pantoprazole Sodium41$879
Atorvastatin Calcium109$825
Rosuvastatin Calcium60$682
Sertraline Hcl27$629
Tamsulosin Hcl37$601
Omeprazole52$570

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$160$48,48035 claims
PfizerEliquis$69$24,87829 claims
Boehringer IngelheimJardiance$111$24,04715 claims
Lilly USA, LLCTrulicity$30$20,83218 claims
AstraZenecaSymbicort$157$4,45115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Huntersville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →